Lemtaz – Aurobindo Pharma

Opposed App ID 5427897 Class 5 Word

Trademark information

IP India · live record
Application ID
5427897
Status
Opposed
Sub status
Not Applicable
Date of application
28 April 2022
Classes
5
Type
Word
Proprietor
Aurobindo Pharma Foundation Plot No. 2, Maitrivihar, Ameerpet,Hyderabad – 500 038, India'
Attorney
Daswani & Daswani[10708]409 Prajay Corporate House,1 10 63 & 64 Chikoti Gardens,Begumpet,Hyderabad 500 016
State
Telangana
Filing mode
e-Filing
IP office
Chennai
Used since
10 November 2010
Valid / upto
—

Goods & services

Class 5

Class 5Medicinal and Pharmaceutical preparations

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 28 Apr 2022
2 Reply to Exam Report (MIS-R) 03 Aug 2022
3 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 08 Sep 2022
4 Authorization Letter 08 Apr 2024
5 Authorization Letter 09 Aug 2024
6 TM-M(EXTENSION OF TIME) 13 Aug 2024
7 TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) 30 Sep 2024
8 Authorization Letter 12 Feb 2025
9 Reply to Exam Report (MIS-R) 19 May 2025
10 Authorization Letter 31 Jul 2025
11 Journal Copy 21 Aug 2025
12 TM-O(NOTICE OF OPPOSITION) 25 Nov 2025
13 TM-O(NOTICE OF OPPOSITION) 28 Nov 2025
14 Annexure -1 under rule 46 15 Jun 2026
15 Annexure -1 under rule 46 15 Jun 2026
16 Evidence Affidavit Under Rule 46 (TOP) 15 Jun 2026
17 Evidence Affidavit Under Rule 46 (TOP) 15 Jun 2026

Correspondence and notices

1 EXAMINATION REPORT 13804632 18 Jul 2022
2 Hearing Notice (Show Cause) 17610757 04 Mar 2024
3 Hearing Notice (Show Cause) 18256389 04 Jun 2024
4 Hearing Notice (Show Cause) 19093812 05 Nov 2024
5 Adjourned Notice 19273758 09 Dec 2024
6 Hearing Notice (Show Cause) 19520682 17 Jan 2025
7 EXAMINATION REPORT 20123395 28 Apr 2025
8 Hearing Notice for Application No. 5427897 20323874 30 May 2025
9 Tribunal Accepted Notice for : 5427897 20648821 · 7362902 31 Jul 2025
10 Opposition Notice 21371781 · 7529566 19 Dec 2025
11 Opposition Notice 21371807 · 7529582 19 Dec 2025
12 Opposition Counter Statement 21846936 · 7649077 19 Feb 2026
13 Opposition Counter Statement 21846963 · 7649103 19 Feb 2026

Frequently asked questions

Lemtaz was applied for on 28 April 2022.

The application was filed by Aurobindo Pharma.

Class 5.

As per IP India, the status is Opposed.

The listed application ID of Lemtaz is 5427897.

Trademark attorney Daswani & Daswani.